CPC C07K 16/40 (2013.01) [A23K 20/147 (2016.05); A23L 33/17 (2016.08); C07K 5/1021 (2013.01); C12N 9/20 (2013.01); C12Y 301/01004 (2013.01); A23V 2002/00 (2013.01); A61K 2039/505 (2013.01); C07K 2317/11 (2013.01); C07K 2317/23 (2013.01); C07K 2317/34 (2013.01); C07K 2317/76 (2013.01)] | 8 Claims |
1. A method of reducing the contribution of the gastrointestinal tract to an inflammatory process, comprising
orally administering to an individual in need thereof an antibody that specifically binds secretory phospholipase A2-IB, wherein the antibody specifically binds a peptide consisting of (V/A/R)PYNK(A/E)(H/Y)K (SEQ ID NO. 6), wherein the antibody is a polyclonal avian egg yolk IgY antibody preparation produced by inoculating laying hens with the peptide.
|